Many Medicines Set To Be Cheaper After 5th Price Cap

KOLKATA : For the fifth consecutive time in the current year, some medicines are set to be cheaper after the National Pharmaceutical Pricing Authority (NPPA) on Tuesday capped prices of 129 drugs. A number of medicines like paracetamol have seen prices declining for the second time this year. However, prices of a few medicines like montelukast and metformin have increased.

The list of 129 drugs that NPPA came out with includes medicines like paracetamol, amoxycillin, rabeprazole and metformin. Many of these are used by patients on a regular basis. Paracetamol (650mg), which is sold for Rs 2.3 per tablet at present, is now capped at Rs 1.8 per tablet. Earlier this year, the NPPA had reduced prices of combination formulation of paracetamol. The price of amoxycillin and potassium clavulanate was also brought down from Rs 22.3 to Rs 16.8 per tablet.

The price of moxifloxacin (400mg) has also been drastically reduced to Rs 22.8 from the current Rs 31.5 per tablet. Used for treating bacterial infections like pneumonia, the price of this medicine was reduced for the first time this year. However, prices of a few medicines like metformin (500mg) were increased from Rs 1.7 to Rs 1.8 in the new list. Used in the treatment of Type II diabetes, prices of combination formulation of metformin have been changed a number of times in the past one year.

Rajiv Singhal, general secretary of the All India Organisation of Chemists and Druggists (AIOCD), said: “This is a welcome move. But some medicines like paracetamol have already seen lowest prices. With the price of active pharmaceutical ingredients (API) on the rise, there is less room left for the manufacturers to curtail the prices further. I hope the supplies are not affected in the future.”

According to Sajal Ganguly, secretary of the Bengal Chemists and Druggists Association (BCDA), medicines with the new price tag will start arriving by January-end. “It normally takes a month for the medicines with new prices to arrive in the market. We should get the new stock by the end of next month,” he said.

  • Related Posts

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    Gleneagles BGS Hospital, Kengeri, Bengaluru, part of the Fortis Healthcare Network, marked World Organ Donation Day with its annual commemorative event, ‘A Legacy That Lives On.’ The event brought together…

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    Punjab: The Narcotics Control Bureau (NCB) has uncovered an alleged pharmaceutical-drug diversion network operating through rural areas of Punjab. Investigators are tracing the movement of fentanyl and other drugs regulated…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

    Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

    ‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

    ‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses